Dandelion Root Extract Enhances the Toxicity of Sunitinib to Renal Cell Carcinoma Cells by Inducing Mitochondrial Dysfunction and Triggering Apoptosis

被引:0
|
作者
Xie, Jiao-gui [1 ]
Jiang, Ying [2 ]
Wang, Yi-chao [2 ,3 ]
He, Li-feng [1 ]
机构
[1] First Peoples Hosp Xianyang, Dept Urol, Xianyang 712099, Shaanxi, Peoples R China
[2] Taizhou Univ, Med Sch, Taizhou 318000, Zhejiang, Peoples R China
[3] First Peoples Hosp Xianyang, Dept Clin Lab Med, Xianyang 712099, Shaanxi, Peoples R China
关键词
dandelion root extract (DRE); mitochondrial dysfunction; renal cell carcinoma (RCC); sunitinib (ST); apoptosis; BIOGENESIS; PROLIFERATION;
D O I
10.23812/j.biol.regul.homeost.agents.20233708.431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: At present, sunitinib (ST) is the most frequently used targeted therapy drug for renal cell carcinoma (RCC). The objective of this study was to investigate whether dandelion root extract (DRE) could improve the curative effect of ST on RCC through in vitro experiments.Methods: First, 786-O human RCC cells were divided into Control, DRE, ST and DRE+ST groups. Next, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and colony formation assays were applied to test the proliferation and viability of 786-O cells, respectively. Cell apoptosis, reactive oxygen species (ROS) levels and changes in mitochondrial membrane poten-tial were detected by flow cytometry. Western blot was used to evaluate protein expression levels of B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), Caspase-3, cleaved-Caspase-3, Caspase-9, apoptosis-inducing factor (AIF), cytochrome c (Cyt-c), cleaved-Caspase-9 and cleaved-poly ADP-ribose polymerase (PARP) in mitochondria. Besides, mitochondrial DNA (mtDNA) content and expression levels of peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1a), mitochon-drial transcription factor A (TFAM), dynamin-related protein 1 (DRP1), mitofusin 1/2 (MFN1/2) were measured by real-time fluorescence quantitative polymerase chain reaction (qRT-PCR). Results: Compared with DRE alone or ST alone, DRE combined with ST significantly increased the toxicity of 786-O cells (p < 0.01), increased ROS accumulation (p < 0.01), promoted apoptosis (p < 0.01), up-regulated the expression level of mitochon-drial apoptosis-related proteins (p < 0.01), decreased mitochondrial membrane potential (p < 0.01), and induced mitochondrial dysfunction in 786-O cells (p < 0.01).Conclusions: DRE may increase the toxicity of ST to RCC cells via inducing mitochondrial dysfunction and triggering apoptosis. Therefore, DRE combined with ST may be a potential treatment option for RCC.
引用
收藏
页码:4403 / 4411
页数:9
相关论文
共 40 条
  • [31] Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells
    Wu, XX
    Kakehi, Y
    Mizutani, Y
    Nishiyama, H
    Kamoto, T
    Megumi, Y
    Ito, N
    Ogawa, O
    INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (04) : 409 - 417
  • [32] Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells
    Li, Hongyan
    Jin, Xuefei
    Zhang, Zhuo
    Xing, Yuanyuan
    Kong, Xiangbo
    CELL BIOCHEMISTRY AND FUNCTION, 2013, 31 (05) : 427 - 433
  • [33] Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo
    Zeng, Y
    Wu, XX
    Fiscella, M
    Shimada, O
    Humphreys, R
    Albert, V
    Kakehi, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (02) : 421 - 430
  • [34] Melatonin acts synergistically with pazopanib against renal cell carcinoma cells through p38 mitogen-activated protein kinase-mediated mitochondrial and autophagic apoptosis
    Lai, Chien-Pin
    Chen, Yong-Syuan
    Ying, Tsung-Ho
    Kao, Cheng-Yen
    Chiou, Hui-Ling
    Kao, Shao-Hsuan
    Hsieh, Yi-Hsien
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2023, 42 (04) : 487 - 500
  • [35] Catechin-7-O-xyloside induces apoptosis via endoplasmic reticulum stress and mitochondrial dysfunction in human non-small cell lung carcinoma H1299 cells
    Yoon, Jang Won
    Lee, Jong Suk
    Kim, Byeong Mo
    Ahn, Joungjwa
    Yang, Kyung Mi
    ONCOLOGY REPORTS, 2014, 31 (01) : 314 - 320
  • [36] Hydrangea serrata extract exerts tumor inhibitory activity against hepatocellular carcinoma HepG2 cells via inducing p27/CDK2-mediated cell cycle arrest and apoptosis
    Kim, Ye-eun
    Hwang, Jeonghye
    Kim, Ki-Young
    ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2024, 14 (02) : 65 - 72
  • [37] Royleanone diterpenoid exhibits potent anticancer effects in LNCaP human prostate carcinoma cells by inducing mitochondrial mediated apoptosis, cell cycle arrest, suppression of cell migration and downregulation of mTOR/PI3K/AKT signalling pathway
    Wu, Xiaoming
    He, Yi
    Zhang, Gaoyue
    Wu, Jianhui
    Hou, Yansong
    Gu, Yanqin
    Chen, Hao
    JOURNAL OF BUON, 2018, 23 (04): : 1055 - 1060
  • [38] Cinnamolide sesquiterpene lactone suppresses in vitro and in vivo cancer cell growth in cisplatin-resistant human cervical carcinoma cells by inducing mitochondrial mediated apoptosis, caspase activation, loss of MMP and targeting Akt/β-Catenin signaling pathway
    Hou, Jing
    Kan, Changli
    Zhu, Yanju
    Zhang, Yi
    Zhou, Bingfeng
    Ren, Chunli
    Fu, Jiuyuan
    Guo, Yanwei
    Zhang, Jinhuan
    JOURNAL OF BUON, 2020, 25 (02): : 709 - 715
  • [39] Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway
    Yang, Qin
    Fei, Zhiyi
    Huang, Chunyan
    CELLULAR AND MOLECULAR BIOLOGY, 2021, 67 (02) : 14 - 19
  • [40] Root extract of Prunella vulgaris inhibits in vitro and in vivo carcinogenesis in MCF-5 human breast carcinoma cells via suppression of angiogenesis, induction of apoptosis, cell cycle arrest and modulation of PI3K/AKT signalling pathway
    Gao, Wei
    Liang, Hua
    Li, Yanlei
    Liu, Yuanyuan
    Xu, Yanxia
    JOURNAL OF BUON, 2019, 24 (02): : 549 - 554